American Journal of Ophthalmology
Volume 139, Issue 4 , Pages 710-711 , April 2005

Measurements, biomarkers, and interpretation

  • Timothy W. Olsen

      Affiliations

    • Corresponding Author InformationInquiries to Timothy W. Olsen, MD, University of Minnesota Department of Ophthalmology, MMC 493, 420 Delaware Street S.E., Minneapolis, MN 55455-0501; fax: 612-625-3693

,Accepted 28 December 2004.

References 

  1. Hera R, Keramidas M, Peoc’HM, Mouillon M, Romanet J, Feige J. Expression of VEGF and angiopoietins in subfoveal membranes from patients with age-related macular degeneration. Am J Ophthalmol 2005;139:589–596.
  2. Hawkins BS , Bressler NM , Miskala PH , et al.   Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: ophthalmic findings: SST report no. 11 . Ophthalmology . 2004;111:1967–1980
  3. Miskala PH , Bass EB , Bressler NM , et al.   Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: quality-of-life findings: SST report no. 12 . Ophthalmology . 2004;111: 1981–1192
  4. Malik KJ , Chen CD , Olsen TW . Stability of RNA from the retina and retinal pigment epithelium in a porcine model simulating human eye bank conditions . Invest Ophthalmol Vis Sci . 2003;44:2730–2735
  5. Frank RN , Amin RH , Eliott D , Puklin JE , Abrams GW . Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes . Am J Ophthalmol . 1996;122:393–403
  6. Grossniklaus HE , Martinez JA , Brown VB , et al.   Immunohistochemical and histochemical properties of surgically excised subretinal neovascular membranes in age-related macular degeneration . Am J Ophthalmol . 1992;114:464–472
  7. Mori K , Duh E , Gehlbach P , et al.   Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization . J Cell Physiol . 2001;188:253–263
  8. Holekamp NM , Bouck N , Volpert O . Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration . Am J Ophthalmol . 2002;134:220–227
  9. Manolio T . Novel risk markers and clinical practice . N Engl J Med . 2003;349:1587–1589
  10. Winkler BS , Boulton ME , Gottsch JD , Sternberg P . Oxidative damage and age-related macular degeneration . Mol Vis . 1999;5:32
  11. Zarbin MA . Current concepts in the pathogenesis of age-related macular degeneration . Arch Ophthalmol . 2004;122:598–614
  12. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. AREDS report no. 8 . Arch Ophthalmol . 2001;119:1417–1436
  13. Olsen TW , Feng X . The Minnesota Grading System of eye bank eyes for age-related macular degeneration . Invest Ophthalmol Vis Sci . 2004;45:4484–4490
  14. Ethen C, Feng X, Olsen TW, Ferrington D. Declines in arrestin and rhodopsin in the macula with progression of AMD. Invest Ophthalmol Vis Sci 2005. Forthcoming.

 Supported by NIA/NIH RO1-AG025392, NEI/NIH RO3-EY014176 Minnesota Lions Macular Degeneration Center Minneapolis, Minnesota; University of Minnesota Vision Foundation, Minneapolis, Minnesota; and unrestricted grant from Research to Prevent Blindness.

PII: S0002-9394(04)01633-2

doi: 10.1016/j.ajo.2004.12.090

American Journal of Ophthalmology
Volume 139, Issue 4 , Pages 710-711 , April 2005

Article Tools